Literature DB >> 4016929

Headache in transient ischemic attacks (TIA).

C Loeb, C Gandolfo, D Dall'Agata.   

Abstract

The evaluation of headache in patients with transient ischemic attacks (TIA) has various sources of difficulty, the definition of TIA being the most relevant. The classical definition needs to be supplemented with a normal CT scan if a misleading diagnostic statement is to be avoided. The clinical features of 90 patients suffering from TIA and who had contrast-enhanced CT scans are reported. Headache occurred in 30% of the patients. Headache prevailed in patients with vertebrobasilar TIA compared with carotid TIA (p less than 0.05). Headache prevailed as a preceding (24 h) and/or concomitant sign compared with other neurological symptoms (77.8% of the patients). Headache was ipsilateral, in the anterior half of the head in the carotid TIA and in the posterior half of the head in the vertebrobasilar TIA. In about 50% of the patients generalized non-localized headache occurred. Headache usually preceded the neurological symptoms in cases of arterial occlusion (20 carotid, 3 vertebral artery), usually appearing during or after the attack in cases without arterial occlusion. Only 2 cases out of 20 with positive CT scan had headache. These two patients suffered from a rather large hypodense lesion. The other 18 patients showed lacunar lesions. Different hypotheses concerning the physiopathology of the headache associated with TIA are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 4016929     DOI: 10.1177/03331024850050S203

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  2 in total

1.  Headache in transient ischemic attacks.

Authors:  Elena R Lebedeva; Natalia M Gurary; Jes Olesen
Journal:  J Headache Pain       Date:  2018-07-27       Impact factor: 7.277

2.  Migraine aura or transient ischemic attacks? A five-year follow-up case-control study of women with transient central nervous system disorders in pregnancy.

Authors:  Janne Marit Ertresvg; Lars Jacob Stovner; Lene Ekern Kvavik; Hans-Jorgen Johnsen; John-Anker Zwart; Grethe Helde; Gunnar Bovim
Journal:  BMC Med       Date:  2007-07-17       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.